TOMI Environmental Solutions (TOMZ)


Market Price (8/8/2026): $1.82 | Market Cap: $12.4 MilSector: Industrials | Industry: Environmental & Facilities Services

TOMI Environmental Solutions (TOMZ)


Market Price (8/8/2026): $1.82
Market Cap: $12.4 Mil
Sector: Industrials
Industry: Environmental & Facilities Services

Investment Highlights Why It Matters Detailed financial logic regarding cash flow yields vs trend-riding momentum.

0

Megatrend and thematic drivers
Megatrends include Global Health & Biosecurity. Themes include Infection Prevention & Control, Advanced Decontamination Solutions, and Environmental Hygiene Technologies.

Not profitable at operating income level
Op Inc LTMOperating Income, Last Twelve Months is -3.7 Mil, Op Mgn LTMOperating Margin = Operating Income / Revenue Reflects profitability before taxes and before impact of capital structure (interest payments). is -65%

Stock price has recently run up significantly
6M Rtn6 month market price return is 156%

Weak revenue growth
Rev Chg LTMRevenue Change % Last Twelve Months (LTM) is -30%, Rev Chg 3Y AvgRevenue Change % averaged over trailing 3 years is -6.9%

Not cash flow generative
CFO/Rev LTMCash Flow from Operations / Revenue (Sales), Last Twelve Months (LTM) is -11%, FCF/Rev LTMFree Cash Flow / Revenue (Sales), Last Twelve Months (LTM) is -12%

Valuation getting more expensive
P/S 6M Chg %Price/Sales change over 6 months. Declining P/S indicates valuation has become less expensive. is 228%

Yield minus risk free rate is negative
ERPEquity Risk Premium (ERP) = Total Yield - Risk Free Rate, Reflects the premium above risk free assets offered by the investment. is -39%

High stock price volatility
Vol 12M is 361%

Key risks
TOMZ key risks include [1] substantial going concern doubt and high bankruptcy risk stemming from significant historical losses, Show more.

0 Megatrend and thematic drivers
Megatrends include Global Health & Biosecurity. Themes include Infection Prevention & Control, Advanced Decontamination Solutions, and Environmental Hygiene Technologies.
1 Not profitable at operating income level
Op Inc LTMOperating Income, Last Twelve Months is -3.7 Mil, Op Mgn LTMOperating Margin = Operating Income / Revenue Reflects profitability before taxes and before impact of capital structure (interest payments). is -65%
2 Stock price has recently run up significantly
6M Rtn6 month market price return is 156%
3 Weak revenue growth
Rev Chg LTMRevenue Change % Last Twelve Months (LTM) is -30%, Rev Chg 3Y AvgRevenue Change % averaged over trailing 3 years is -6.9%
4 Not cash flow generative
CFO/Rev LTMCash Flow from Operations / Revenue (Sales), Last Twelve Months (LTM) is -11%, FCF/Rev LTMFree Cash Flow / Revenue (Sales), Last Twelve Months (LTM) is -12%
5 Valuation getting more expensive
P/S 6M Chg %Price/Sales change over 6 months. Declining P/S indicates valuation has become less expensive. is 228%
6 Yield minus risk free rate is negative
ERPEquity Risk Premium (ERP) = Total Yield - Risk Free Rate, Reflects the premium above risk free assets offered by the investment. is -39%
7 High stock price volatility
Vol 12M is 361%
8 Key risks
TOMZ key risks include [1] substantial going concern doubt and high bankruptcy risk stemming from significant historical losses, Show more.

Valuation & Metrics

Price Chart

Why The Stock Moved

Qualitative Assessment

AI Analysis | Feedback

Updated on 8/6/2026

TOMI Environmental Solutions (TOMZ) stock has gained about 170% since 4/30/2026 because of the following key factors:

1. Transformative Merger Agreement with Carbonium Core, Inc.

TOMI Environmental Solutions executed a non-binding letter of intent on April 30, 2026, and subsequently signed a definitive merger agreement with Carbonium Core, Inc., a U.S.-based producer of nuclear-grade graphite for advanced reactor technologies and AI data center infrastructure. This strategic move, expected to close in the second half of fiscal year 2026, implies an enterprise valuation of $120 million for Carbonium Core and significantly diversifies TOMI's business into the high-growth nuclear materials sector. Carbonium Core targets a potential $1.5 billion annual revenue opportunity and is supported by the U.S. Department of Energy in its pilot study for nuclear-grade graphite production.

2. Strong Fiscal Q2 2026 Preliminary Revenue and Reaffirmed Fiscal Year Guidance.

The company reported a preliminary 124% year-over-year increase in revenue for fiscal Q2 2026, reaching approximately $2.3 million, surpassing consensus estimates of $1.84 million. All four key business metrics, including BIT Solution sales, mobile equipment sales, single applicator sales, and support services, demonstrated year-over-year and sequential growth during this quarter. Furthermore, TOMI reaffirmed its fiscal 2026 revenue guidance of at least $12 million, noting that first-half fiscal 2026 sales and receipts more than doubled 2025 levels and already exceeded full-year 2025 sales. The company also reported a robust $35 million sales pipeline, with approximately $8.6 million in advanced stages, and secured over $6.2 million in booked orders expected to be completed before year-end fiscal 2026.

Show more
Updated on 8/6/2026

TOMI Environmental Solutions (TOMZ) stock has gained about 170% since 4/30/2026 because of the following key factors:

1. Transformative Merger Agreement with Carbonium Core, Inc.

TOMI Environmental Solutions executed a non-binding letter of intent on April 30, 2026, and subsequently signed a definitive merger agreement with Carbonium Core, Inc., a U.S.-based producer of nuclear-grade graphite for advanced reactor technologies and AI data center infrastructure. This strategic move, expected to close in the second half of fiscal year 2026, implies an enterprise valuation of $120 million for Carbonium Core and significantly diversifies TOMI's business into the high-growth nuclear materials sector. Carbonium Core targets a potential $1.5 billion annual revenue opportunity and is supported by the U.S. Department of Energy in its pilot study for nuclear-grade graphite production.

2. Strong Fiscal Q2 2026 Preliminary Revenue and Reaffirmed Fiscal Year Guidance.

The company reported a preliminary 124% year-over-year increase in revenue for fiscal Q2 2026, reaching approximately $2.3 million, surpassing consensus estimates of $1.84 million. All four key business metrics, including BIT Solution sales, mobile equipment sales, single applicator sales, and support services, demonstrated year-over-year and sequential growth during this quarter. Furthermore, TOMI reaffirmed its fiscal 2026 revenue guidance of at least $12 million, noting that first-half fiscal 2026 sales and receipts more than doubled 2025 levels and already exceeded full-year 2025 sales. The company also reported a robust $35 million sales pipeline, with approximately $8.6 million in advanced stages, and secured over $6.2 million in booked orders expected to be completed before year-end fiscal 2026.

3. Expanding International Market Penetration and Regulatory Approvals.

TOMI has successfully expanded its international footprint, securing SteraMist regulatory approvals in ten European countries, with additional approvals anticipated in several others. The company has also deepened global partnerships, including collaborations in Poland and new partnerships in Argentina targeting major global accounts. In the defense sector, TOMI received approvals from defense contractors in Korea and defense agencies in Canada, and is actively working with the U.S. Defense Logistics Agency to streamline government procurement of its SteraMist technology. Additionally, on August 3, 2026, TOMI received EPA registration for SteraMist, expanding its use to post-harvest agricultural food safety, including cannabis and hemp cultivation.

Show less
Holding a concentrated position? Know your true downside before the momentum shifts.
Protect Your Wealth →

Stock Movement Drivers

Fundamental Drivers

The 171.6% change in TOMZ stock from 4/30/2026 to 8/7/2026 was primarily driven by a 170.8% change in the company's P/S Multiple.
(LTM values as of)43020268072026Change
Stock Price ($)0.671.82171.6%
Change Contribution By: 
Total Revenues ($ Mil)661.4%
P/S Multiple0.82.2170.8%
Shares Outstanding (Mil)77-1.1%
Cumulative Contribution171.6%

LTM = Last Twelve Months as of date shown

Market Drivers

4/30/2026 to 8/7/2026
ReturnCorrelation
TOMZ171.6% 
Market (SPY)7.6%1.2%
Sector (XLI)6.1%-9.9%

Fundamental Drivers

The 146.0% change in TOMZ stock from 1/31/2026 to 8/7/2026 was primarily driven by a 149.2% change in the company's P/S Multiple.
(LTM values as of)13120268072026Change
Stock Price ($)0.741.82146.0%
Change Contribution By: 
Total Revenues ($ Mil)660.4%
P/S Multiple0.92.2149.2%
Shares Outstanding (Mil)77-1.7%
Cumulative Contribution146.0%

LTM = Last Twelve Months as of date shown

Market Drivers

1/31/2026 to 8/7/2026
ReturnCorrelation
TOMZ146.0% 
Market (SPY)12.1%3.7%
Sector (XLI)12.2%-5.5%

Fundamental Drivers

The 87.6% change in TOMZ stock from 7/31/2025 to 8/7/2026 was primarily driven by a 174.8% change in the company's P/S Multiple.
(LTM values as of)73120258072026Change
Stock Price ($)0.971.8287.6%
Change Contribution By: 
Total Revenues ($ Mil)86-30.3%
P/S Multiple0.82.2174.8%
Shares Outstanding (Mil)77-2.0%
Cumulative Contribution87.6%

LTM = Last Twelve Months as of date shown

Market Drivers

7/31/2025 to 8/7/2026
ReturnCorrelation
TOMZ87.6% 
Market (SPY)23.4%2.8%
Sector (XLI)23.1%-4.7%

Fundamental Drivers

The 139.5% change in TOMZ stock from 7/31/2023 to 8/7/2026 was primarily driven by a 228.9% change in the company's P/S Multiple.
(LTM values as of)73120238072026Change
Stock Price ($)0.761.82139.5%
Change Contribution By: 
Total Revenues ($ Mil)86-24.9%
P/S Multiple0.72.2228.9%
Shares Outstanding (Mil)77-3.0%
Cumulative Contribution139.5%

LTM = Last Twelve Months as of date shown

Market Drivers

7/31/2023 to 8/7/2026
ReturnCorrelation
TOMZ139.5% 
Market (SPY)74.9%3.6%
Sector (XLI)74.7%-1.6%

Return vs. Risk

Price Returns Compared

 202120222023202420252026Total [1]
Returns
TOMZ Return-64%-11%-32%4%-26%136%-60%
Peers Return9%-30%40%4%12%3%28%
S&P 500 Return27%-19%24%23%16%13%105%

Monthly Win Rates [3]
TOMZ Win Rate17%33%50%50%25%50% 
Peers Win Rate57%38%62%52%50%55% 
S&P 500 Win Rate75%42%67%75%67%50% 

Max Drawdowns [4]
TOMZ Max Drawdown-81%-73%-66%-47%-43%-75% 
Peers Max Drawdown-16%-43%-21%-20%-20%-24% 
S&P 500 Max Drawdown-5%-25%-10%-8%-19%-9% 


[1] Cumulative total returns since the beginning of 2021
[2] Peers: STE, FTV, SHC, ECL, SYK.
[3] Win Rate = % of calendar months in which monthly returns were positive
[4] Max drawdown represents maximum peak-to-trough decline within a year
[5] 2026 data is for the year up to 8/7/2026 (YTD)

How Low Can It Go

EventTOMZS&P 500
2025 US Tariff Shock
  % Loss-25.0%-18.8%
  % Gain to Breakeven33.3%23.1%
  Time to Breakeven53 days79 days
2024 Yen Carry Trade Unwind
  % Loss-13.3%-7.8%
  % Gain to Breakeven15.3%8.5%
  Time to Breakeven9 days18 days
2023 SVB Regional Banking Crisis
  % Loss-35.3%-6.7%
  % Gain to Breakeven54.6%7.1%
  Time to Breakeven71 days31 days
2022 Inflation Shock & Fed Tightening
  % Loss-65.3%-24.5%
  % Gain to Breakeven188.3%32.4%
  Time to Breakeven1406 days427 days
Q4 2018 Fed Policy Error / Growth Scare
  % Loss-15.0%-19.2%
  % Gain to Breakeven17.6%23.8%
  Time to Breakeven35 days105 days
2016-2017 Trump Reflation Bond Selloff
  % Loss-74.3%-3.7%
  % Gain to Breakeven288.9%3.9%
  Time to Breakeven960 days6 days

Compare to STE, FTV, SHC, ECL, SYK

In The Past

TOMI Environmental Solutions's stock fell -25.0% during the 2025 US Tariff Shock. Such a loss loss requires a 33.3% gain to breakeven.

Preserve Wealth

Limiting losses and compounding gains is essential to preserving wealth.

Asset Allocation

Actively managed asset allocation strategies protect wealth. Learn more.

EventTOMZS&P 500
2025 US Tariff Shock
  % Loss-25.0%-18.8%
  % Gain to Breakeven33.3%23.1%
  Time to Breakeven53 days79 days
2023 SVB Regional Banking Crisis
  % Loss-35.3%-6.7%
  % Gain to Breakeven54.6%7.1%
  Time to Breakeven71 days31 days
2022 Inflation Shock & Fed Tightening
  % Loss-65.3%-24.5%
  % Gain to Breakeven188.3%32.4%
  Time to Breakeven1406 days427 days
2016-2017 Trump Reflation Bond Selloff
  % Loss-74.3%-3.7%
  % Gain to Breakeven288.9%3.9%
  Time to Breakeven960 days6 days
2015-2016 China Devaluation / Global Growth Scare
  % Loss-40.9%-12.2%
  % Gain to Breakeven69.3%13.9%
  Time to Breakeven15 days62 days
2014-2016 Oil Price Collapse
  % Loss-33.1%-6.8%
  % Gain to Breakeven49.6%7.3%
  Time to Breakeven22 days15 days
2011 US Debt Ceiling Crisis & European Contagion
  % Loss-80.0%-17.9%
  % Gain to Breakeven400.0%21.8%
  Time to Breakeven265 days123 days
2010 Eurozone Sovereign Debt Crisis / Flash Crash
  % Loss-86.7%-15.4%
  % Gain to Breakeven650.0%18.2%
  Time to Breakeven1065 days125 days

Compare to STE, FTV, SHC, ECL, SYK

In The Past

TOMI Environmental Solutions's stock fell -25.0% during the 2025 US Tariff Shock. Such a loss loss requires a 33.3% gain to breakeven.

Preserve Wealth

Limiting losses and compounding gains is essential to preserving wealth.

Asset Allocation

Actively managed asset allocation strategies protect wealth. Learn more.

About TOMI Environmental Solutions (TOMZ)

TOMI Environmental Solutions, Inc. (TOMZ) is a company specializing in bacteria decontamination and infectious disease control. It provides environmental solutions primarily for indoor surface decontamination, leveraging its proprietary Binary Ionization Technology (BIT), which is a hydrogen peroxide-based mist and fog, to achieve high-level disinfection and sterilization.

The core of TOMI's offering centers on its SteraMist product line. Key products include the portable SteraMist Surface Unit for targeted disinfection, the transportable SteraMist Environment System for complete room disinfection of sealed spaces, and the SteraMist Hospital Disinfection Cart tailored for critical healthcare environments. In addition to equipment sales, TOMI also provides iHP Corporate Service Decontamination, offering comprehensive full-room, equipment, and facility disinfection services.

TOMI serves a broad and diverse customer base across various sectors requiring stringent decontamination. Its clients include hospitals and medical facilities, bio-safety and pharmaceutical labs, meat and produce processing facilities, universities, and vivariums. The company's solutions are also utilized in cruise ships, office buildings, hotels, schools, military barracks, police and fire departments, prisons, athletic facilities, and both single-family and multi-unit residences, demonstrating the wide applicability of its disinfection technologies.

AI Analysis | Feedback

Imagine **Orkin or Terminix, but for invisible germs and infectious diseases** instead of pests, offering specialized high-tech solutions for decontamination in various environments.

They're like **a highly specialized version of Ecolab, focused exclusively on advanced atmospheric and surface disinfection** using their proprietary SteraMist technology.

AI Analysis | Feedback

  • SteraMist Surface Unit: A portable, handheld, point-and-spray system for quick disinfection and decontamination of affected spaces.
  • SteraMist Environment System: A transportable, remotely controlled system designed for complete room disinfection and decontamination of sealed spaces.
  • The SteraMist Hospital Disinfection Cart: A mobile solution for healthcare facilities to disinfect patient rooms, operating rooms, pharmacies, and emergency environments.
  • SteraMist Select Surface Unit: A specialized variant of the SteraMist Surface Unit offering targeted disinfection capabilities.
  • Stainless Steel 90-Degree Applicator: An accessory designed to enhance the application of SteraMist products in specific angles and hard-to-reach areas.
  • iHP Plasma Decontamination Chamber: A chamber system utilizing iHP technology for controlled decontamination of items and equipment.
  • SteraMist Custom Engineered System: Tailored disinfection and decontamination systems designed to meet specific client requirements.
  • iHP Corporate Service Decontamination: A comprehensive service providing full room, equipment, facility, and emergency disinfection and decontamination for various industries.
  • SteraMist Binary Ionization Technology (BIT): The proprietary hydrogen peroxide-based mist and fog technology that underpins their decontamination products, offered through manufacturing, sales, service, and licensing.

AI Analysis | Feedback

TOMI Environmental Solutions (symbol: TOMZ) primarily sells its products and services to other companies, organizations, and government entities, rather than directly to individuals. The provided background information does not list specific names of customer companies. However, it extensively details the categories of facilities and industries that are their major customers.

Based on the company description, TOMI Environmental Solutions serves the following major categories of institutional and commercial customers:

  1. Healthcare and Life Sciences Facilities: This includes hospitals, medical facilities, bio-safety labs, pharmaceutical facilities, universities and research facilities, and vivarium labs. Their products are used for disinfecting patient rooms, operating rooms, pharmacies, ambulances, and emergency environments.
  2. Commercial and Hospitality Sector: This broad category covers a variety of commercial spaces such as cruise ships, office buildings, hotel and motel rooms, schools, restaurants, and athletic facilities.
  3. Industrial and Public Service Organizations: This encompasses meat and produce processing facilities, military barracks, police and fire departments, and prisons. They also provide decontamination services for single-family homes and multi-unit residences, likely through property management or professional service companies.

AI Analysis | Feedback

null

AI Analysis | Feedback

Dr. Halden S. Shane, Chief Executive Officer & Chairman

Dr. Shane is the founder of TOMI Environmental Solutions, Inc., serving as CEO and Chairman since the company's inception in 1979. He was also the founder and CEO of Integrated Healthcare Alliance, Inc., and the founder and General Partner of Doctors Hospital West Covina, California. From 1999 to 2009, Dr. Shane served as President and CEO of Tiger Management International, a private management company, which he subsequently resigned from and closed in 2009. Before his corporate roles, he practiced podiatric surgery, specializing in ankle arthroscopy.

David Vanston, Chief Financial Officer

Mr. Vanston was appointed Chief Financial Officer of TOMI Environmental Solutions, Inc. effective May 30, 2025. He brings over 25 years of international financial leadership experience across the life sciences, manufacturing, and technology sectors. His previous roles include CFO positions at Jon-Don LLC, Flexan LLC (a subsidiary of ILC Dover), Arcmed-Diba Industries, and VolitionRx, a multinational epigenetics company listed on the NYSE. Mr. Vanston has experience in senior finance roles at both private equity-backed and publicly traded companies. He holds an MBA from Warwick University and is a Fellow of the Chartered Certified Accountants in the United Kingdom.

Elissa J. Shane, Chief Operating Officer & Director

Ms. Shane has served as Chief Operating Officer and Director since August 2, 2021. She began her career with TOMI Environmental Solutions, Inc. in August 2015 as the Chief Regulatory and Compliance Officer. She also held the positions of Secretary of the Company from January 2016 to December 2017 and Operations and Compliance Officer from December 2016 to December 2017. Prior to joining TOMI, Ms. Shane worked as a paralegal for firms such as Levi Lubarsky Feigenbaum & Weiss LLP, The Lustigman Firm PC, Olshan Frome Wolosky LLP, Fried Frank Harris Shriver & Jacobson, and Kenyon & Kenyon LLP, where she managed regulatory and compliance issues, litigation procedures, and advertising matters.

Brittany Buchman, Vice President of Marketing and Communications

Ms. Buchman has been the Vice President of Marketing and Communications at TOMI Environmental Solutions, Inc. since 2017, where she is responsible for developing and executing marketing and advertising strategies. Her diverse work experience includes roles as a Marketing Associate at America's Remote Help Desk (2012-2015) and All Covered (2015), and Marketing Coordinator at Dream Yacht Charter (2015-2016). She also served as a Promotions/Advertising Administrator at CACI International Inc. (2016-2017). Ms. Buchman earned her Bachelor's degree in Business Administration with a minor in Marketing from Shepherd University (2008-2012) and holds certifications in Google Analytics and Google Ads Search.

AI Analysis | Feedback

The key risks to TOMI Environmental Solutions (TOMZ) predominantly revolve around its reliance on a core product line, its financial performance, and the ongoing viability of its proprietary technology in a competitive market.

  1. Heavy Reliance on SteraMist® Product Line and Intense Competition: TOMI Environmental Solutions is highly dependent on its SteraMist® product line, which generates the majority of its revenue. This reliance poses a significant risk because the disinfection and decontamination industry is intensely competitive. If the SteraMist® product loses its competitive edge, or if new, more effective, or more cost-efficient technologies emerge, it could severely impact TOMI's market position and revenue.

  2. Sustained Net Losses and Need for Additional Capital: The company has consistently reported net losses and operating losses in recent fiscal years. As of early 2024, TOMI also maintained a low cash position and was actively seeking additional funding to support its operations and growth initiatives. The company's financial health is further challenged by its balance sheet, which has been described as "far from match-fit" with negative free cash flow. Without long-term customer contracts, TOMI is also vulnerable to competitive price pressures and uncertainty in future sales, contributing to its financial instability.

  3. Risk of Intellectual Property Challenges or Technological Obsolescence: TOMI's business is built on its proprietary Binary Ionization Technology (BIT), marketed under the SteraMist® brand, which is a patented technology. While TOMI has successfully defended its patents and continues to file new applications, there is an inherent risk that the patents protecting this core technology could eventually expire. Furthermore, if the technology is superseded by superior alternatives developed by competitors, or if regulatory concerns arise, it could undermine the foundation of TOMI's business model.

AI Analysis | Feedback

null

AI Analysis | Feedback

The addressable markets for TOMI Environmental Solutions (TOMZ) main products and services encompass several global and regional segments within the disinfection and decontamination industry. Here are the market sizes for their main products or services: * **Global Infection Control Market:** The global infection control market was valued at approximately USD 52.38 billion in 2024 and is projected to reach USD 74.21 billion by 2030, growing at a Compound Annual Growth Rate (CAGR) of 6.1% from 2025 to 2030. North America held the largest revenue share in this market, accounting for 48.3% in 2024. Another report indicates the market was valued at USD 56.73 billion in 2025 and is projected to reach USD 97.55 billion by 2034, with a CAGR of 6.21% from 2026 to 2034. * **Global Bio Decontamination Market:** The global bio decontamination market was estimated at USD 222.96 million in 2023 and is expected to grow at a CAGR of 8.62% from 2024 to 2030, reaching USD 396.49 million by 2030. Other estimates place the market at USD 238 million in 2023, projected to reach USD 339 million by 2028 with a CAGR of 7.3%. Another forecast suggests a market size of USD 229.5 million in 2023, estimated to reach USD 525.4 million by 2033 at a CAGR of 8.7% from 2024 to 2033. North America held a significant share of this market, accounting for 46% in 2023. The hydrogen peroxide segment, which is integral to TOMI's technology, held the largest market share in 2026, valued at USD 143.6 million. * **Global Surface Disinfectant Market:** The global surface disinfectant market was estimated at USD 6.68 billion in 2025 and is projected to reach USD 11.66 billion by 2033, with a CAGR of 7.2% from 2026 to 2033. Another report states the market was valued at USD 3.48 billion in 2024 and is expected to reach USD 6.56 billion by 2032, growing at a CAGR of 8.22% during the forecast period (2025-2032). North America dominated the surface disinfectant market with a 33.4% revenue share in 2025. * **Global Hospital Disinfectant Products Market:** The global hospital disinfectant products market size was valued at USD 9.55 billion in 2024 and is projected to grow to USD 11.88 billion by 2034, exhibiting a CAGR of 3.2% during the forecast period. The global hospital surgical disinfectant market, a sub-segment, was valued at USD 490.9 million in 2025 and is projected to reach USD 993.0 million by 2035, registering a CAGR of 7.3%. North America is expected to be the largest market for hospital surgical disinfectants, holding over 42.3% of the market share in 2025. * **Global Healthcare Disinfectants and Sanitizers Market:** The global healthcare disinfectants and sanitizers market size was valued at USD 16.80 billion in 2024 and is projected to grow to USD 39.01 billion by 2033, with a CAGR of 9.21% during the forecast period (2025-2033). An alternative estimate for this market indicates a value of USD 14.34 billion in 2023, expected to reach USD 39.18 billion by 2033, growing at a CAGR of 10.57%. * **Global Antiseptic and Disinfectant Market:** This broader market, which includes both antiseptics and disinfectants, was valued at USD 31.85 billion in 2023 and is anticipated to reach approximately USD 89.62 billion by 2033, growing at a CAGR of 10.9% from 2024 to 2033. North America dominated this market, accounting for a 34.63% revenue share in 2023.

AI Analysis | Feedback

TOMI Environmental Solutions (symbol: TOMZ) is expected to drive future revenue growth over the next 2-3 years through several key initiatives and market expansions:

  1. Increased Sales of Consumable BIT Solution: A primary driver of recurring, high-margin revenue is the continued sale of its proprietary Binary Ionization Technology (BIT) Solution, which is essential for the operation of its SteraMist equipment. The company reported a significant 159% year-over-year increase in BIT Solution sales in January 2025 compared to January 2024, demonstrating strong momentum in this segment. This "razor-and-blade" model ensures a steady income stream after initial equipment sales.
  2. Expansion of iHP Corporate Service Decontamination and Training: TOMI's iHP Corporate Service Decontamination business and overall service and training revenue are experiencing substantial growth. This segment achieved a record quarterly performance in Q3 2024 and saw an 89% increase in completed services in January 2025 compared to the previous year. Service and training revenues increased by 33% in Q2 2025 and 46% for the first half of 2025, indicating rising demand for its specialized decontamination services.
  3. Entry into New Markets and Verticals: The company is actively expanding its market presence both geographically and into new industry sectors. Management has expressed optimism for growth in international markets and is focusing on diversifying SteraMist applications across new sectors such as food safety, biosecurity, pharmaceutical onshoring, agriculture, and data centers.
  4. Growth in Mobile Equipment Sales: Sales of TOMI's mobile equipment, such as the SteraMist Surface Unit, continue to be a significant revenue driver. This category saw a substantial 90% year-over-year increase in Q3 2024 and contributed to overall revenue growth in Q4 2024 with a 23% increase. The launch of new products like the SteraMist Integrated System is also expected to contribute to this growth.
  5. Strategic Partnerships and Custom Integration Projects: TOMI is leveraging strategic partnerships and custom integration projects to expand its reach and secure larger-scale initiatives. The company is developing a $3 million custom integration pipeline with ten active projects in the life sciences sector, signaling strong future growth potential. Additionally, expanding the SteraMist Pro Certified program to include in-house service providers and new product development are key to sustained growth.

AI Analysis | Feedback

Share Issuance

  • TOMI Environmental Solutions Inc. reported approximately 20.23 million shares outstanding as of November 12, 2025.
  • The company's shares outstanding were approximately 20 million as of a recent quarter, with a quarter-over-quarter increase of 0.7%.
  • The number of shares outstanding has shown fluctuations over the period from 2014 to 2025.

Capital Expenditures

  • TOMI Environmental Solutions Inc. had capital expenditures of approximately $108K in a recent period, which consumed most of its operating cash flow, resulting in -$1.5M in free cash flow.

Better Bets vs. TOMI Environmental Solutions (TOMZ)

Latest Trefis Analyses

Title
0ARTICLES

Recent Active Movers

Peer Comparisons

Peers to compare with:

Financials

TOMZSTEFTVSHCECLSYKMedian
NameTOMI Env.Steris Fortive Sotera H.Ecolab Stryker  
Mkt Price1.82237.4761.7118.86285.17339.03149.59
Mkt Cap0.023.218.85.480.0130.021.0
Rev LTM65,9364,3161,21616,84225,8375,126
Op Inc LTM-41,1067873993,0465,615946
FCF LTM-19721,0401131,8744,7021,006
FCF 3Y Avg-27881,251861,8413,8431,019
CFO LTM-11,3411,0512923,0575,5251,196
CFO 3Y Avg-21,1541,3302612,8614,5691,242

Growth & Margins

TOMZSTEFTVSHCECLSYKMedian
NameTOMI Env.Steris Fortive Sotera H.Ecolab Stryker  
Rev Chg LTM-30.3%8.7%5.6%8.1%7.1%8.5%7.6%
Rev Chg 3Y Avg-6.9%9.4%-8.4%7.7%4.5%9.9%6.1%
Rev Chg Q4.9%7.3%7.9%9.2%9.7%9.4%8.5%
QoQ Delta Rev Chg LTM1.4%1.8%1.9%2.3%2.4%2.2%2.1%
Op Inc Chg LTM-2.6%15.1%9.4%27.5%12.1%20.4%13.6%
Op Inc Chg 3Y Avg-3.0%11.8%-4.4%23.2%17.8%16.4%14.1%
Op Mgn LTM-65.2%18.6%18.2%32.8%18.1%21.7%18.4%
Op Mgn 3Y Avg-52.9%17.7%16.8%29.6%17.0%20.4%17.3%
QoQ Delta Op Mgn LTM3.2%0.3%0.6%0.8%-0.0%1.5%0.7%
CFO/Rev LTM-10.9%22.6%24.4%24.0%18.1%21.4%22.0%
CFO/Rev 3Y Avg-22.4%20.9%32.3%22.8%17.8%19.1%20.0%
FCF/Rev LTM-12.2%16.4%24.1%9.3%11.1%18.2%13.8%
FCF/Rev 3Y Avg-24.8%14.2%30.4%7.4%11.5%16.1%12.8%

Valuation

TOMZSTEFTVSHCECLSYKMedian
NameTOMI Env.Steris Fortive Sotera H.Ecolab Stryker  
Mkt Cap0.023.218.85.480.0130.021.0
P/S2.23.94.34.44.85.04.4
P/Op Inc-3.321.023.913.526.323.222.1
P/EBIT-3.321.023.713.227.122.521.7
P/E-2.929.735.133.037.834.933.9
P/CFO-19.817.317.918.426.223.518.2
Total Yield-34.7%4.4%3.1%3.0%3.6%3.9%3.4%
Dividend Yield0.0%1.0%0.3%0.0%1.0%1.0%0.6%
FCF Yield 3Y Avg-28.6%3.6%6.2%2.3%2.5%2.9%2.7%
D/E0.30.10.20.40.20.10.2
Net D/E0.30.10.20.40.10.10.1

Returns

TOMZSTEFTVSHCECLSYKMedian
NameTOMI Env.Steris Fortive Sotera H.Ecolab Stryker  
1M Rtn-28.5%13.4%0.7%8.0%4.0%3.7%3.9%
3M Rtn120.9%14.8%2.2%19.5%12.5%19.1%16.9%
6M Rtn155.6%-5.3%2.9%6.3%-1.2%-4.9%0.8%
12M Rtn77.6%1.6%30.6%68.1%6.8%-9.0%18.7%
3Y Rtn160.0%8.6%3.6%9.8%58.9%23.6%16.7%
1M Excs Rtn-26.8%7.1%-1.9%-0.3%1.6%0.8%0.3%
3M Excs Rtn151.0%5.7%-4.3%14.6%5.7%9.8%7.8%
6M Excs Rtn125.4%-16.2%-11.4%-5.7%-14.3%-20.1%-12.8%
12M Excs Rtn58.8%-13.8%8.0%48.3%-15.0%-30.9%-2.9%
3Y Excs Rtn74.4%-64.5%-67.7%-69.8%-12.8%-44.7%-54.6%

Comparison Analyses

null

Financials

Segment Financials

Revenue by Segment
$ Mil20252024202320222021
Product46   
Service22   
Service and Training  212
SteraMist Product  676
Total68788


Price Behavior

Price Behavior
Market Price$1.82 
Market Cap ($ Bil)0.0 
First Trading Date06/24/2008 
Distance from 52W High-34.8% 
   50 Days200 Days
DMA Price$1.38$0.90
DMA Trendupup
Distance from DMA31.9%101.5%
 3M1YR
Volatility592.9%361.3%
Downside Capture-240.0760.06
Upside Capture152.15110.96
Correlation (SPY)2.7%3.2%
TOMZ Betas & Captures as of 7/31/2026

 1M2M3M6M1Y3Y
Beta-2.06-0.860.191.150.640.48
Up Beta1.595.06-6.61-8.37-4.11-0.68
Down Beta26.3611.288.067.904.221.58
Up Capture-3%-420%123%387%90%38%
Bmk +ve Days11223567138427
Stock +ve Days10193063117338
Down Capture-1520%-493%-477%110%49%76%
Bmk -ve Days11212859114326
Stock -ve Days11223160128390

[1] Upside and downside betas calculated using positive and negative benchmark daily returns respectively
Based On 1-Year Data
Annualized
Return
Annualized
Volatility
Sharpe
Ratio
Correlation
with TOMZ
TOMZ81.5%360.6%1.19-
Sector ETF (XLI)24.1%17.0%1.10-4.8%
Equity (SPY)23.3%12.8%1.362.9%
Gold (GLD)28.5%28.4%0.872.4%
Commodities (DBC)32.9%19.8%1.32-0.1%
Real Estate (VNQ)14.2%13.8%0.72-6.9%
Bitcoin (BTCUSD)-44.2%42.9%-1.23-2.0%

Smart multi-asset allocation framework can stack odds in your favor. Learn How
Based On 5-Year Data
Annualized
Return
Annualized
Volatility
Sharpe
Ratio
Correlation
with TOMZ
TOMZ-5.2%202.6%0.60-
Sector ETF (XLI)14.0%17.6%0.62-0.5%
Equity (SPY)13.5%17.2%0.614.3%
Gold (GLD)18.6%18.6%0.813.0%
Commodities (DBC)8.2%19.6%0.311.5%
Real Estate (VNQ)2.3%18.9%0.020.4%
Bitcoin (BTCUSD)8.8%53.0%0.351.9%

Smart multi-asset allocation framework can stack odds in your favor. Learn How
Based On 10-Year Data
Annualized
Return
Annualized
Volatility
Sharpe
Ratio
Correlation
with TOMZ
TOMZ-3.2%182.4%0.65-
Sector ETF (XLI)14.2%20.0%0.62-2.7%
Equity (SPY)15.4%17.9%0.730.4%
Gold (GLD)12.1%16.2%0.61-0.3%
Commodities (DBC)7.4%18.0%0.330.1%
Real Estate (VNQ)4.8%20.7%0.20-3.1%
Bitcoin (BTCUSD)58.2%66.2%0.980.7%

Smart multi-asset allocation framework can stack odds in your favor. Learn How

Short Interest

Short Interest: As Of Date7152026
Short Interest: Shares Quantity0.0 Mil
Short Interest: % Change Since 6302026-73.7%
Average Daily Volume0.1 Mil
Days-to-Cover Short Interest1
Basic Shares Quantity6.8 Mil
Short % of Basic Shares0.3%

Earnings Returns History

Updated 8/7/2026
Expand for More
 Forward Returns
Earnings Date1D Returns5D Returns21D Returns
7/29/2026-7.9%17.0% 
5/8/2026-2.8%-5.7%9.9%
11/14/2025-8.6%-4.2%-8.6%
8/14/2025-2.1%-14.1%-10.6%
5/8/20251.9%6.0%34.8%
10/30/2024-6.5%-6.7%-21.8%
8/1/2024-8.2%-5.5%15.8%
5/15/2024-6.0%-6.0%47.5%
...
SUMMARY STATS   
# Positive7510
# Negative141610
Median Positive4.1%16.8%21.4%
Median Negative-8.1%-9.1%-16.2%
Max Positive8.7%22.0%53.2%
Max Negative-41.2%-48.0%-62.3%
Collapse to Preview
 Forward Returns
Earnings Date1D Returns5D Returns21D Returns
7/29/2026-7.9%17.0% 
5/8/2026-2.8%-5.7%9.9%
11/14/2025-8.6%-4.2%-8.6%
8/14/2025-2.1%-14.1%-10.6%
5/8/20251.9%6.0%34.8%
10/30/2024-6.5%-6.7%-21.8%
8/1/2024-8.2%-5.5%15.8%
5/15/2024-6.0%-6.0%47.5%
11/14/20237.4%16.8%0.0%
8/14/20233.0%22.0%10.0%
5/15/2023-8.8%-16.9%-2.6%
3/16/20234.1%11.1%27.6%
11/10/20222.3%-7.3%-9.4%
8/15/2022-4.5%-13.1%-32.5%
5/5/20226.8%-10.3%27.1%
11/12/20218.7%-2.4%53.2%
8/16/2021-18.3%-15.7%14.7%
5/17/2021-16.4%-12.8%-2.7%
3/30/2021-7.8%-7.8%-22.4%
11/12/2020-25.0%-33.1%-39.2%
8/13/2020-41.2%-48.0%-62.3%
SUMMARY STATS   
# Positive7510
# Negative141610
Median Positive4.1%16.8%21.4%
Median Negative-8.1%-9.1%-16.2%
Max Positive8.7%22.0%53.2%
Max Negative-41.2%-48.0%-62.3%

SEC Filings

Expand for More
Report DateFiling DateFiling
03/31/202605/08/202610-Q
12/31/202503/31/202610-K
09/30/202511/14/202510-Q
06/30/202508/14/202510-Q
03/31/202505/08/202510-Q
12/31/202404/14/202510-K
09/30/202410/30/202410-Q
06/30/202408/01/202410-Q
03/31/202405/15/202410-Q
12/31/202304/01/202410-K
09/30/202311/14/202310-Q
06/30/202308/14/202310-Q
03/31/202305/15/202310-Q
12/31/202203/16/202310-K
09/30/202211/10/202210-Q
06/30/202208/15/202210-Q
Collapse to Preview
Report DateFiling DateFiling
03/31/202605/08/202610-Q
12/31/202503/31/202610-K
09/30/202511/14/202510-Q
06/30/202508/14/202510-Q
03/31/202505/08/202510-Q
12/31/202404/14/202510-K
09/30/202410/30/202410-Q
06/30/202408/01/202410-Q
03/31/202405/15/202410-Q
12/31/202304/01/202410-K
09/30/202311/14/202310-Q
06/30/202308/14/202310-Q
03/31/202305/15/202310-Q
12/31/202203/16/202310-K
09/30/202211/10/202210-Q
06/30/202208/15/202210-Q
03/31/202205/05/202210-Q
12/31/202103/29/202210-K
09/30/202111/15/202110-Q
06/30/202108/16/202110-Q
03/31/202105/17/202110-Q
12/31/202003/30/202110-K
09/30/202011/13/202010-Q
06/30/202008/14/202010-Q
03/31/202005/14/202010-Q
12/31/201903/30/202010-K
09/30/201911/14/201910-Q
06/30/201908/14/201910-Q

Recent Forward Guidance

Updated 7/30/2026

Latest: Q2 2026 Earnings Reported 7/29/2026

Forward GuidanceGuidance Change
MetricLowMidHigh% Chg% DeltaChangePrior
2026 Revenue 12.00 Mil   Affirmed
2026 Sales Pipeline 35.00 Mil    
2026 Advanced Sales Pipeline 8.60 Mil    

Prior: Q1 2026 Earnings Reported 5/8/2026

Forward GuidanceGuidance Change
MetricLowMidHigh% Chg% DeltaChangePrior
2026 Integration Pipeline 4.30 Mil    

Q3 2025 Earnings Reported 11/14/2025

Forward GuidanceGuidance Change
MetricLowMidHigh% Chg% DeltaChangePrior
2025 Pending Contracts 3.00 Mil 50.0% RaisedGuidance: 2.00 Mil for 2025
Core Cache Last Updated: 8/7/2026